Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

Texas will fully fund clinical trials into the medical effects of ibogaine

A program designed to conduct drug development clinical trials for a psychedelic drug in Texas hit a road bump after the state could not find a drug company to help develop a FDA-approved drug.

Former Texas Governor Drops Jaw-Dropping Claim On Rogan

This post was republished with permission from VigilantFo Former Texas Governor Rick Perry blows Joe Rogan away when he reveals 98% of people overcome opioid addiction after just two doses of Ibogaine. “That is amazing! That is truly amazing.” Former Texas Governor blows Joe Rogan away when he reveals 98% of people overcome opioid addiction after just two doses of Ibogaine.“That is amazing! That is truly amazing.”“There’s nothing even remotely l…

Texas to launch independent psychedelic study after drug companies miss mark

After losing faith in potential drug company partners, Texas is planning to launch an independent study into the medical application of ibogaine, a naturally occurring plant with psychedelic properties that's been promising for PTSD and other mental maladies.

Texas Will Launch Ibogaine Clinical Trials After Drug Companies Failed To Meet Requirements For Psychedelic Research Funds

“We intend to fully fund this program.” By Stephen Simpson, The Texas Tribune Texas is launching its own research program into a psychedelic called ibogaine after state officials couldn’t find a company to help develop it into a drug for Food and Drug Administration (FDA) approval. Lt. Gov. Dan Patrick (R) and House Speaker Dustin Burrows (R) announced on Tuesday that Texas will use $50 million the Legislature invested last year and partner with…

Texas to conduct its own ibogaine clinical trials

The Legislature last year approved $50 million to research the psychedelic and find a company to develop it into a drug for FDA approval.

Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

The Legislature last year approved $50 million to research the psychedelic and find a company to develop it into a drug for FDA approval.